title: [Cutting-edge of medicine; management of heart failure with biomarkers--how to interpret the JHFS(Japanese Heart Failure Society) statement for BNP use].
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Saito
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood; D002309:Cardiology / Q000458:organization & administration*; D015870:Gene Expression; D006333:Heart Failure / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007564:Japan; D020097:Natriuretic Peptide, Brain / Q000097:blood* / Q000235:genetics; D010446:Peptide Fragments / Q000097:blood; D017410:Practice Guidelines as Topic; D012016:Reference Values; D012084:Renin-Angiotensin System; D012955:Societies, Medical / Q000458:organization & administration*
chemical_list: D000319:Adrenergic beta-Antagonists; D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain